When Authority Speaks Without Understanding: Why Some Doctors Still Don’t Get Tobacco Harm Reduction

This was brought on by a thread on X, the kind of thread that doesn’t just sit quietly in the background but circulates, is endorsed, reshared, and absorbed as if it reflects settled truth. It carried the tone of authority, as many posts from clinicians do, particularly when they speak on matters of public health. But authority is not the same as understanding, and confidence is not the same as accuracy.

What stood out in the thread was not any single statement, but the underlying framework that shaped it. There was a clear assumption running through the discussion: that nicotine use, in any form, is inherently undesirable, and that the only acceptable endpoint is complete abstinence. This framing is common, especially among doctors who approach the issue from a traditional cessation model. It is clean, simple, and morally clear. But it does not align with how people actually behave, nor does it align with the full body of evidence on tobacco harm reduction.

Tobacco harm reduction is built on a very simple idea. Combustion causes the overwhelming majority of smoking-related diseases. If you remove combustion, you remove most of the harm. This is not a fringe claim. It is the foundation of modern tobacco science. And yet, in many public discussions led by medical professionals, this distinction is blurred or ignored entirely. Smoking and vaping are often discussed as if they exist on the same continuum of harm, when in reality they are separated by a substantial margin.

This gap in understanding is not just academic. It has real consequences. When doctors present vaping as equally harmful to smoking, or close enough to make no meaningful difference, they remove one of the most viable alternatives available to people who cannot or will not quit nicotine entirely. For many smokers, switching to a lower-risk product is not about achieving perfection. It is about making a meaningful health improvement. Harm reduction accepts that reality. It does not demand ideal behaviour before offering better options.

The issue becomes more pronounced when this kind of messaging is amplified on social platforms like X. Social media rewards certainty. Nuance is compressed. Complex ideas are reduced to statements that can be quickly understood and widely shared. In that environment, a cautious, evidence-based explanation of relative risk competes poorly against a firm, declarative statement that presents a simple narrative. The result is that simplified or incomplete interpretations of the evidence can gain traction, especially when they come from individuals with professional credentials.

Doctors occupy a unique position in society. Their words carry weight not just because of what they say, but because of who they are. When a doctor speaks on public health, the assumption is that their position is grounded in a deep understanding of the evidence. But that assumption does not always hold, particularly in areas that fall outside direct clinical training. Tobacco harm reduction is one of those areas. It sits at the intersection of epidemiology, behavioural science, and population-level policy. It requires an understanding of risk in relative terms, not just absolute ones. That distinction is not always part of traditional medical education.

As a result, many doctors approach nicotine through a lens that is more aligned with addiction management than with harm reduction. In that framework, nicotine is seen as the problem to be eliminated, rather than as a substance that can be delivered in safer ways. This leads to a subtle but important shift in thinking. Instead of asking “how do we reduce the most harm for the most people,” the question becomes “how do we eliminate this behaviour?” Those are not the same question, and they do not lead to the same outcomes.

The consequences of this shift are often overlooked. If policy and messaging are driven by an elimination mindset, then any alternative that does not fit that model is treated with suspicion. Safer nicotine products are not evaluated on their ability to reduce harm compared to smoking. Instead, they are often judged against an ideal of zero use. That standard, while understandable from a purist perspective, is not achievable for many people. And when achievable improvements are dismissed because they are not perfect, the result is stagnation.

There is also a broader issue of how risk is communicated. In some medical commentary, there is a tendency to focus heavily on potential risks while giving less attention to relative risk. This creates a distorted perception. If a behaviour is described in isolation, without context, it can appear more dangerous than it actually is. When that behaviour is compared to a far more harmful one, the picture changes significantly. But that comparison is often missing in public discussions led by clinicians, particularly on social media.

This matters because public perception is shaped by these messages. People who smoke and are trying to make decisions about their health are exposed to conflicting information. On one hand, they are told that all nicotine use is harmful and should be avoided. On the other hand, they may hear from individuals who have successfully switched to lower-risk alternatives and experienced improvements in their health. When the messaging from trusted professionals dismisses or downplays those alternatives, it can discourage people from making changes that would benefit them.

It is important to be clear that this is not about blaming individual doctors. Most are acting in good faith. They are trying to protect patients from harm, which is a fundamental part of their role. But good intentions do not guarantee good outcomes. In fact, when good intentions are paired with incomplete or outdated understanding, they can reinforce ineffective or even counterproductive approaches.

The challenge is not to undermine medical authority, but to expand the scope of what that authority includes. Doctors need to be able to engage with harm reduction not as an abstract concept, but as a practical tool. That requires a willingness to move beyond binary thinking. It requires accepting that in many cases, the choice is not between perfect and imperfect, but between better and worse.

Tobacco harm reduction sits firmly in that space. It is not about promoting nicotine use. It is about recognising that nicotine delivery systems are not all equal, and that choosing a less harmful option can have significant public health benefits. Ignoring that distinction does not eliminate nicotine use. It simply removes one of the pathways that can reduce the harm associated with it.

What is striking about the thread on X is how clearly it reflects this tension. It presents a confident position, grounded in a familiar public health narrative, but it does not fully engage with the complexity of the issue. That is not unusual. It is, in fact, increasingly common. But as these conversations continue to shape public perception, it becomes more important to highlight where understanding ends and assumption begins.

Because at its core, this is not just a disagreement about nicotine. It is a disagreement about how we approach harm itself. Whether we insist on eliminating it or whether we accept that reducing it is sometimes the most realistic and impactful path forward. And that distinction will continue to define the debate, long after the thread has faded from view.